Sangamo BioSciences Reports Fourth Quarter And Full Year 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
Sangamo Biosciences (SGMO) Tops Q4 EPS by 1c
February 9, 2016 4:05 PM ESTSangamo Biosciences (NASDAQ: SGMO) reported Q4 EPS of ($0.20), $0.01 better than the analyst estimate of ($0.21). Revenue for the quarter came in at $9.1 million versus the consensus estimate of $9.86 million.
For earnings history and earnings-related data on Sangamo Biosciences (SGMO) click here.
... More